Brand-name drug
Xigduo price, strengths & recalls
Brand of dapagliflozin / metformin (generic)
Pharmacies pay $576.04 for 30 tablets of Xigduo 10 mg / 1000 mg (24 hr) extended-release tablet this week, and from $287.73 to $576.98 across its 5 priced strengths and forms. The generic, dapagliflozin / metformin, costs pharmacies from $14.61. It has 2 recalls on record, none ongoing. Its official label last changed on August 26, 2026.
Brand- Fair cash price
- $672.95
- Strengths
- 5
- Makers
- 1
- Updated
- Nov 11
Xigduo price by strength
What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay |
|---|---|---|
| 2.5 mg / 1000 mg (24 hr) extended-release tablet Brand | $9.61 | $288.40 / 30 tablets |
| 5 mg / 1000 mg (24 hr) extended-release tablet Brand | $9.59 | $287.73 / 30 tablets |
| 5 mg / 500 mg (24 hr) extended-release tablet Brand | $19.18 | $575.27 / 30 tablets |
| 10 mg / 1000 mg (24 hr) extended-release tablet Brand | $19.20 | $576.04 / 30 tablets |
| 10 mg / 500 mg (24 hr) extended-release tablet Brand | $19.23 | $576.98 / 30 tablets |
The lowest cost per tablet is 5 mg / 1000 mg (24 hr) extended-release tablet at $9.59. Strengths aren't interchangeable - ask your pharmacist or prescriber before changing.
Xigduo vs generic dapagliflozin / metformin
Generics have the same active ingredient, strength and form, and FDA requires them to work the same way. What pharmacies pay for each, same quantity:
| Strength | Brand | Generic | Brand costs |
|---|---|---|---|
| 5 mg / 1000 mg (24 hr) extended-release tablet | $287.73 | $14.61 | 19.7x |
| 5 mg / 500 mg (24 hr) extended-release tablet | $575.27 | $21.18 | 27.2x |
| 10 mg / 1000 mg (24 hr) extended-release tablet | $576.04 | $24.44 | 23.6x |
| 10 mg / 500 mg (24 hr) extended-release tablet | $576.98 | $22.76 | 25.3x |
Supply status: shortages & recalls
Recalls
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
What people paid for Xigduo
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
These highlights do not include all the information needed to use XIGDUO XR safely and effectively. See full prescribing information for XIGDUO XR.XIGDUO® XR (dapagliflozin and metformin hydrochloride extended-release) tablets, for oral useInitial U.S. Approval: 2014
WARNING: LACTIC ACIDOSIS
• Postmarketing cases of metformin-associated lactic acidosis have resulted in death, hypothermia, hypotension, and resistant bradyarrhythmias. The onset of metformin-associated lactic acidosis is often subtle, accompanied only by non-specific symptoms such as malaise, myalgias, respiratory distress, somnolence, and abdominal pain. Metformin-associated lactic acidosis was characterized by elevated blood lactate levels (>5 mmol/L), anion gap acidosis (without evidence of ketonuria or ketonemia), an increased lactate/pyruvate ratio; and metformin plasma levels generally >5 mcg/mL [see Warnings and Precautions (5.1)].
• Risk factors for metformin-associated lactic acidosis include renal impairment, concomitant use of certain drugs (e.g., carbonic anhydrase inhibitors such as topiramate), age 65 years old or greater, having a radiological study with contrast, surgery and other procedures, hypoxic states (e.g., acute congestive heart failure), excessive alcohol intake, hepatic impairment and mitochondrial diseases [see Warnings and Precautions (5.1)].
• Steps to reduce the risk of and manage metformin-associated lactic acidosis in these high-risk groups are provided in the full prescribing information [see Dosage and Administration (2.1 and 2.4), Contraindications (4), Warnings and Precautions (5.1), Drug Interactions (7), and Use in Specific Populations (8.6, 8.7)].
• If metformin-associated lactic acidosis is suspected, immediately discontinue XIGDUO XR and institute general supportive measures in a hospital setting. Prompt hemodialysis is recommended [see Warnings and Precautions (5.1)].
WARNING: LACTIC ACIDOSIS
See full prescribing information for complete boxed warning.
•
Postmarketing cases of metformin-associated lactic acidosis have resulted in death, hypothermia, hypotension, and resistant bradyarrhythmias. Symptoms included malaise, myalgias, respiratory distress, somnolence, and abdominal pain. Laboratory abnormalities included elevated blood lactate levels, anion gap acidosis, increased lactate/pyruvate ratio; and metformin plasma levels generally >5 mcg/mL. (5.1)
•
Risk factors include renal impairment, concomitant use of certain drugs, age >65 years old, radiological studies with contrast, surgery and other procedures, hypoxic states, excessive alcohol intake, hepatic impairment, and mitochondrial diseases. Steps to reduce the risk of and manage metformin-associated lactic acidosis in these high risk groups are provided in the Full Prescribing Information. (5.1)
•
If lactic acidosis is suspected, discontinue XIGDUO XR and institute general supportive measures in a hospital setting. Prompt hemodialysis is recommended. (5.1)
Recent major changes (as listed on the label)
Boxed Warning 08/2026
Dosage and Administration 08/2026
Recommendations Regarding Missed Dose (2.7)
Warnings and Precautions 08/2026
Lactic Acidosis (5.1)
Genitourinary Infections, including Urosepsis, Pyelonephritis, Necrotizing Fasciitis of the Perineum (Fournier's Gangrene), and Genital Mycotic Infections (5.4)
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Application
- NDA205649 · Astrazeneca Ab
- First approved
- October 29, 2014 (12 years ago)
- Latest approved change
- August 11, 2026
- Approved label
- PDF, Aug 18, 2026
- Generic makers
- 6 approved generic applications on the market
- Last patent listed
- May 12, 2031
- Exclusivity ends
- December 12, 2027
Xigduo questions
How much does xigduo cost without insurance?
Pharmacies pay about $576.04 for 30 tablets of xigduo 10 mg / 1000 mg (24 hr) extended-release tablet ($19.20 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $672.95. If you're quoted much more, check your quote and ask for the pharmacy's cash price.
Is there a generic for Xigduo?
Yes: dapagliflozin / metformin. Pharmacies pay from $14.61 for it. Compare dapagliflozin / metformin prices.
Is xigduo in shortage?
No shortage is reported for xigduo right now. We check the national shortage list every day.
Has xigduo been recalled?
2 recalls on record, none ongoing. Recalls name specific lots - check yours.
When did the xigduo label last change?
The official label was last updated on August 26, 2026 (version 40). See what changed.
Talk about xigduo
No comments yet. Questions, tips, what worked for you - start the conversation.